2m 2m 2m 2m 2m 2m 2m
KALA BIO (KALA)
NASDAQ
$3.13+$0.005 (+0.16%)
Price as of Jun 23, 2026 7:33 PM EDT- $65.8MMarket Cap
- -98.24%1-Year Change
- BiotechnologyIndustry
KALA BIO (KALA)
$3.13+$0.005 (+0.16%)
KALA | vs History | vs S&P 500 | |
|---|---|---|---|
General Statistics | |||
Latest Close | $3.12 | ||
Change | -$0.07 (-1.94%) | ||
Open | $3.36 | ||
High | $3.54 | ||
Low | $3.11 | ||
Previous Close | $3.54 | ||
Volume | 67,649 | ||
30-Day Average Volume | 157,387 | ||
1-Week Change | 34.09% | ||
1-Month Change | 45.68% | ||
1-Year Change | -98.24% | ||
3-Year Change | -99.51% | ||
5-Year Change | -99.98% | ||
Fundamentals | |||
Shares Outstanding | 18.6M | ||
Total Assets | $12.3M | ||
Market Cap | $65.8M | ||
Enterprise Value | $64.0M | ||
Period: QTR TTM FY | |||
Revenue | N/A | ||
Net Income | -$1.6M | ||
Free Cash Flow | -$2.9M | ||
EBIT | -$1.6M | ||
EBITDA | -$1.6M | ||
Net Working Capital | $10.8M | ||
EPS | -$7.00 | ||
Enterprise Value/EBITDA | -41 | ||
Enterprise Value/Revenue | N/A | ||
P/B | 6 | ||
P/E | -1 | ||
PEG | 0 | ||
Price/Free Cash Flow | -23 | ||
Price/Operating Cash Flow | -23 | ||
Dividends & Splits | |||
Forward Annual Dividend Yield | N/A | ||
Trailing Annual Dividend Yield | N/A | ||
Ex-Dividend Date | N/A | ||
Last Split Factor | 1 : 50 | ||
Last Split Date | 05/11/2026 | ||
Earnings & Revenue